Department of Animal Science and Aquaculture, Dalhousie University, Truro, NS B2N 5E3, Canada.
J Anim Sci. 2023 Jan 3;101. doi: 10.1093/jas/skad083.
This study investigated the effect of folic acid (FA) and its delivery routes (in-feed or in ovo) on broiler chicken's hatch and growth performance, blood biochemistry, anti-oxidant status, and intestinal morphology. A total of 1,860 Cobb 500 hatching eggs were incubated for 21 d. On day 12 of incubation, viable eggs were randomly allotted to four groups: the noninjected group, in ovo saline (injected with 0.1 mL/egg of saline solution), in ovo FA 1 (injected with 0.1 ml FA containing 0.1 mg/egg; FA1), and in ovo FA 2 (injected with 0.1 ml FA containing 0.15 mg/egg). All in ovo treatments were delivered via the amnion. At hatch, chicks were re-allotted to five new treatment groups: FA1, FA2, in-feed FA (FA 3; 5mg/kg in feed), in-feed bacitracin methylene disalicylate (BMD; 55 mg/kg in feed), and negative control (NC; corn-wheat-soybean diet) in 6 replicate pens (22 birds/pen) and raised in starter (days 0 to14), grower (days 15 to 24), and finisher (days 25 to 35) phases. Hatch parameters were assessed on day 0, and body weight and feed intake (FI) were determined weekly. On day 25, 1 bird/cage was euthanized, immune organs weighed, and intestinal tissues harvested. Blood samples were collected for biochemistry and anti-oxidant (Superoxide dismutase-SOD and Malondialdehyde-MDA) analysis. Data were analyzed in a randomized complete block design. While FA1 and FA2 decreased (P < 0.001) hatchability in a dose-dependent manner, FA2 caused a 2% increase (P < 0.05) in average chick weight compared to the noninjected group. Compared to the BMD treatment, FA3 decreased (P < 0.05) average FI across all feeding phases. At the end of the trial on day 35, FA2 had similar feed conversion ratio as the BMD treatment while recording less (P < 0.001) FI. FA1 and FA2 recorded a tendency (P < 0.1) to increase MDA levels and SOD activity by 50% and 19%, respectively, compared to the NC treatment. Compared to NC treatment, FA2 increased (P < 0.01) villus height, width, and villus height to crypt depth ratio in the duodenum, and villus width in the jejunum. Besides its negative effect on hatchability, FA2 may help improve embryonic development and anti-oxidant status in broiler chickens.
本研究旨在探讨叶酸(FA)及其投药途径(饲料添加或胚内注射)对肉鸡孵化和生长性能、血液生化、抗氧化状态和肠道形态的影响。将 1860 枚科布 500 枚孵化蛋孵育 21 天。在孵育的第 12 天,将存活的鸡蛋随机分配到四个组:非注射组、胚内盐水(注射 0.1ml/枚盐水溶液)、胚内 FA1(注射含有 0.1mg/枚 FA 的 0.1ml)和胚内 FA2(注射含有 0.15mg/枚 FA 的 0.1ml)。所有胚内处理均通过羊膜进行。在孵化时,雏鸡被重新分配到五个新的处理组:FA1、FA2、饲料 FA(FA3;饲料中 5mg/kg)、饲料杆菌肽亚甲二水杨酸(BMD;饲料中 55mg/kg)和阴性对照(NC;玉米-小麦-大豆饮食),在 6 个重复栏(22 只/栏)中饲养,并在起始期(第 0 至 14 天)、生长期(第 15 至 24 天)和育肥期(第 25 至 35 天)进行饲养。在第 0 天评估孵化参数,每周测定体重和采食量(FI)。在第 25 天,每笼 1 只鸡被安乐死,测量免疫器官重量,并采集肠道组织。采集血液样本进行生化和抗氧化分析(超氧化物歧化酶-SOD 和丙二醛-MDA)。数据采用随机完全区组设计进行分析。FA1 和 FA2 以剂量依赖的方式降低(P <0.001)孵化率,而 FA2 使平均雏鸡体重比非注射组增加 2%(P <0.05)。与 BMD 处理相比,FA3 降低(P <0.05)了所有饲养阶段的平均 FI。在试验结束时,即第 35 天,FA2 的饲料转化率与 BMD 处理相似,而 FI 则降低(P <0.001)。与 NC 处理相比,FA1 和 FA2 分别记录到 MDA 水平和 SOD 活性增加了 50%和 19%,有增加的趋势(P <0.1)。与 NC 处理相比,FA2 增加了十二指肠绒毛高度、宽度和绒毛高度与隐窝深度比,空肠绒毛宽度。除了对孵化率的负面影响外,FA2 可能有助于改善肉鸡胚胎发育和抗氧化状态。